Technical Analysis for RTRX - Retrophin, Inc.

Grade Last Price % Change Price Change
grade F 22.2 -1.55% -0.35
RTRX closed down 1.55 percent on Friday, January 18, 2019, on 1.5 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical RTRX trend table...

Date Alert Name Type % Chg
Jan 18 BB Squeeze Ended Range Expansion 0.00%
Jan 17 20 DMA Resistance Bearish -1.55%
Jan 17 Bollinger Band Squeeze Range Contraction -1.55%
Jan 17 NR7 Range Contraction -1.55%
Jan 16 Fell Below 20 DMA Bearish -0.98%
Jan 16 180 Bearish Setup Bearish Swing Setup -0.98%
Jan 16 Bollinger Band Squeeze Range Contraction -0.98%
Jan 16 Outside Day Range Expansion -0.98%
Jan 15 20 DMA Support Bullish -5.05%
Jan 15 Bollinger Band Squeeze Range Contraction -5.05%

Older signals for RTRX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Retrophin, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orphan drugs for the treatment of rare and life-threatening diseases. The company develops treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other catastrophic diseases. Its products include RE-021, a small molecule angiotensin receptor blocker and selective endothelin receptor antagonist for the treatment of FSGS; and RE-024, a drug that restores the disruption in the biochemical Coenzyme A pathway caused by the non-functioning PANK2 encoded enzyme. The company also develops RE-001, a recombinant fusion protein that substitutes the dystrophin that is lacking in DMD patients; and RE-003, an investigational agent for spinal muscular atrophy. The company was founded in 2011 and is based in New York, New York.
Is RTRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 33.0
52 Week Low 20.09
Average Volume 376,639
200-Day Moving Average 26.5161
50-Day Moving Average 23.9342
20-Day Moving Average 22.697
10-Day Moving Average 23.068
Average True Range 1.0814
ADX 24.34
+DI 11.8295
-DI 20.8741
Chandelier Exit (Long, 3 ATRs ) 20.8458
Chandelier Exit (Short, 3 ATRs ) 24.0242
Upper Bollinger Band 24.0906
Lower Bollinger Band 21.3034
Percent B (%b) 0.32
BandWidth 12.280037
MACD Line -0.3123
MACD Signal Line -0.3269
MACD Histogram 0.0146
Fundamentals Value
Market Cap 852.15 Million
Num Shares 38.4 Million
EPS -1.84
Price-to-Earnings (P/E) Ratio -12.07
Price-to-Sales 6.36
Price-to-Book 3.08
PEG Ratio -1.05
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.19
Resistance 3 (R3) 23.22 22.91 23.03
Resistance 2 (R2) 22.91 22.66 22.90 22.97
Resistance 1 (R1) 22.56 22.51 22.41 22.53 22.91
Pivot Point 22.25 22.25 22.18 22.24 22.25
Support 1 (S1) 21.90 22.00 21.75 21.87 21.49
Support 2 (S2) 21.59 21.85 21.58 21.43
Support 3 (S3) 21.24 21.59 21.38
Support 4 (S4) 21.21